PTGS2 and breast cancer: The correlation analysis of TCGA-BRCA (breast cancer) revealed several inflammatory pathways associated with increased tumor NOS2/COX2 expression (Fig. 1A) that influenced clinical outcomes (Fig. 1B), including the antitumor-associated IFNγ, TNFα, IL2, IL1, and IL17 pathways (Fig. 1A).